146 related articles for article (PubMed ID: 37847317)
1. A pilot randomized, placebo-controlled, double-blind study of omega-3 fatty acids to prevent paclitaxel-associated acute pain syndrome in breast cancer patients: Alliance A22_Pilot2.
Tawfik B; Dayao ZR; Brown-Glaberman UA; Pankratz VS; Lafky JM; Loprinzi CL; Barton DL
Support Care Cancer; 2023 Oct; 31(12):637. PubMed ID: 37847317
[TBL] [Abstract][Full Text] [Related]
2. Can pregabalin prevent paclitaxel-associated neuropathy?--An ACCRU pilot trial.
Shinde SS; Seisler D; Soori G; Atherton PJ; Pachman DR; Lafky J; Ruddy KJ; Loprinzi CL
Support Care Cancer; 2016 Feb; 24(2):547-553. PubMed ID: 26155765
[TBL] [Abstract][Full Text] [Related]
3. A pilot study of minocycline for the prevention of paclitaxel-associated neuropathy: ACCRU study RU221408I.
Pachman DR; Dockter T; Zekan PJ; Fruth B; Ruddy KJ; Ta LE; Lafky JM; Dentchev T; Le-Lindqwister NA; Sikov WM; Staff N; Beutler AS; Loprinzi CL
Support Care Cancer; 2017 Nov; 25(11):3407-3416. PubMed ID: 28551844
[TBL] [Abstract][Full Text] [Related]
4. Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial.
Ghoreishi Z; Esfahani A; Djazayeri A; Djalali M; Golestan B; Ayromlou H; Hashemzade S; Asghari Jafarabadi M; Montazeri V; Keshavarz SA; Darabi M
BMC Cancer; 2012 Aug; 12():355. PubMed ID: 22894640
[TBL] [Abstract][Full Text] [Related]
5. North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study.
Leal AD; Qin R; Atherton PJ; Haluska P; Behrens RJ; Tiber CH; Watanaboonyakhet P; Weiss M; Adams PT; Dockter TJ; Loprinzi CL;
Cancer; 2014 Jun; 120(12):1890-7. PubMed ID: 24619793
[TBL] [Abstract][Full Text] [Related]
6. Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.
Reeves BN; Dakhil SR; Sloan JA; Wolf SL; Burger KN; Kamal A; Le-Lindqwister NA; Soori GS; Jaslowski AJ; Kelaghan J; Novotny PJ; Lachance DH; Loprinzi CL
Cancer; 2012 Oct; 118(20):5171-8. PubMed ID: 22415454
[TBL] [Abstract][Full Text] [Related]
7. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
[TBL] [Abstract][Full Text] [Related]
8. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin-associated neuropathy characteristics compared with those associated with other neurotoxic chemotherapy agents (Alliance A151724).
Albany C; Dockter T; Wolfe E; Le-Rademacher J; Wagner-Johnston N; Einhorn L; Lafky JM; Smith E; Pachman D; Staff N; Ma C; Loprinzi CL; Costello BA
Support Care Cancer; 2021 Feb; 29(2):833-840. PubMed ID: 32500206
[TBL] [Abstract][Full Text] [Related]
10. Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy.
Hershman DL; Unger JM; Crew KD; Minasian LM; Awad D; Moinpour CM; Hansen L; Lew DL; Greenlee H; Fehrenbacher L; Wade JL; Wong SF; Hortobagyi GN; Meyskens FL; Albain KS
J Clin Oncol; 2013 Jul; 31(20):2627-33. PubMed ID: 23733756
[TBL] [Abstract][Full Text] [Related]
11. Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.
Greenlee H; Crew KD; Capodice J; Awad D; Buono D; Shi Z; Jeffres A; Wyse S; Whitman W; Trivedi MS; Kalinsky K; Hershman DL
Breast Cancer Res Treat; 2016 Apr; 156(3):453-464. PubMed ID: 27013473
[TBL] [Abstract][Full Text] [Related]
12. Patient factors associated with discrepancies between patient-reported and clinician-documented peripheral neuropathy in women with breast cancer receiving paclitaxel: A pilot study.
Salgado TM; Liu J; Reed HL; Quinn CS; Syverson JG; Le-Rademacher J; Lopez CL; Beutler AS; Loprinzi CL; Vangipuram K; Smith EML; Henry NL; Farris KB; Hertz DL
Breast; 2020 Jun; 51():21-28. PubMed ID: 32193049
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy-induced peripheral neuropathy as a predictor of neuropathic pain in breast cancer patients previously treated with paclitaxel.
Reyes-Gibby CC; Morrow PK; Buzdar A; Shete S
J Pain; 2009 Nov; 10(11):1146-50. PubMed ID: 19595634
[TBL] [Abstract][Full Text] [Related]
14. Persistent weekly paclitaxel-induced peripheral neuropathy in early breast cancer patients enrolled in a randomized trial of cryotherapy.
Shigematsu H; Kimura Y; Itagaki T; Yasui D
Medicine (Baltimore); 2023 Apr; 102(16):e33580. PubMed ID: 37083796
[TBL] [Abstract][Full Text] [Related]
15. Patient-reported and clinician-reported chemotherapy-induced peripheral neuropathy in patients with early breast cancer: Current clinical practice.
Nyrop KA; Deal AM; Reeder-Hayes KE; Shachar SS; Reeve BB; Basch E; Choi SK; Lee JT; Wood WA; Anders CK; Carey LA; Dees EC; Jolly TA; Kimmick GG; Karuturi MS; Reinbolt RE; Speca JC; Muss HB
Cancer; 2019 Sep; 125(17):2945-2954. PubMed ID: 31090930
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial using surgical gloves to prevent chemotherapy-induced peripheral neuropathy by paclitaxel in breast cancer patients (AIUR trial).
Kang YJ; Yoon CI; Yang YJ; Baek JM; Kim YS; Jeon YW; Rhu J; Yi JP; Kim D; Oh SJ
BMC Cancer; 2023 Jun; 23(1):570. PubMed ID: 37340369
[TBL] [Abstract][Full Text] [Related]
17. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1.
Loprinzi CL; Reeves BN; Dakhil SR; Sloan JA; Wolf SL; Burger KN; Kamal A; Le-Lindqwister NA; Soori GS; Jaslowski AJ; Novotny PJ; Lachance DH
J Clin Oncol; 2011 Apr; 29(11):1472-8. PubMed ID: 21383290
[TBL] [Abstract][Full Text] [Related]
18. Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
de Boer IH; Zelnick LR; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
JAMA; 2019 Nov; 322(19):1899-1909. PubMed ID: 31703120
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial of cryotherapy to prevent paclitaxel-induced peripheral neuropathy (RU221511I); an ACCRU trial.
Ruddy KJ; Le-Rademacher J; Lacouture ME; Wilkinson M; Onitilo AA; Vander Woude AC; Grosse-Perdekamp MT; Dockter T; Tan AD; Beutler A; Loprinzi CL
Breast; 2019 Dec; 48():89-97. PubMed ID: 31590108
[TBL] [Abstract][Full Text] [Related]
20. Hemoglobin, Body Mass Index, and Age as Risk Factors for Paclitaxel- and Oxaliplatin-Induced Peripheral Neuropathy.
Mizrahi D; Park SB; Li T; Timmins HC; Trinh T; Au K; Battaglini E; Wyld D; Henderson RD; Grimison P; Ke H; Geelan-Small P; Marker J; Wall B; Goldstein D
JAMA Netw Open; 2021 Feb; 4(2):e2036695. PubMed ID: 33587134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]